Research News and Research

RSS

Researchers discover a molecular indicator and regulator of social isolation in female mice

As we have experienced during the COVID pandemic, loneliness, or perceived social isolation, is a major stress for social animals and increases the risk of various mental and physical health issues such as depression, substance abuse, obesity, and premature death.

9 Feb 2022

Surveillance for potentially zoonotic viruses in rodent and bat populations in an agricultural settlement in Ghana

In a new study, researchers investigated viruses in bats and rodents - key reservoir hosts for zoonotic viral pathogens, in a small agricultural community in Ghana.

9 Feb 2022

Polio, chickenpox, measles, now covid. It’s time to consult history on school vaccine mandates

The rapid spread of omicron across the nation — and the finding that vaccines continue to provide strong protection against severe disease — brings covid-19 one step closer, perhaps, to truly earning its place on the list of diseases that have been tamed by vaccines.

9 Feb 2022

Study finds 50% increase in hospitalizations for alcoholic hepatitis in early months of the pandemic

In new research published in Liver International, researchers at Henry Ford Health System have found that people hospitalized for alcoholic hepatitis – a life threatening liver disease fueled by alcohol use – increased a staggering 50 percent in the early months of the COVID-19 pandemic.

9 Feb 2022

30-year-old cancer drug could get another shot, study says

A study by Virginia Commonwealth University Massey Cancer Center researchers published in today's print edition of Molecular Cancer Therapeutics shows that triplatin is effective against triple negative breast cancer, which is the most aggressive form of breast cancer and has few targeted therapies.

9 Feb 2022

Reducing mucin secretion provides a way to control chemoresistance of colorectal cancers

Drugs which are commonly-used as the first line of treatment for colorectal cancer cause the tumor cells to oversecrete proteins known as mucins, according to a new study published today in the journal eLife.

9 Feb 2022

Research provides insights into the effects of Covid-19 lockdown on early development

An international consortium with researchers from 13 countries has investigated the impact of Covid-19 related social isolation measures on 2,200 young infants and toddlers between 8 and 36 months of age.

9 Feb 2022

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

The origin of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has long been debated among scientists. However, prior research found early genetic material of a unique SARS-CoV-2 variant from the soil on King George Island, Antarctica between 24 December 2018 and 13th January 2019.

9 Feb 2022

Reviewing breath biomarkers for inflammatory respiratory diseases

The prevalence of inflammatory airway diseases such as lung cancer, chronic obstructive pulmonary disease (COPD) and asthma is on the rise internationally, placing strain on health systems around the world. Lung cancer is the leading cause of death of all cancers.

From Owlstone Medical Ltd 8 Feb 2022

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury and the risk of blood clots in severe COVID-19 and other disorders that cause immune-mediated damage to the lungs, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

8 Feb 2022

Researchers identify a bivalent histone-mark switch essential for angiogenesis

Defying conventional epigenomic wisdom, the non-conventional polycomb (PRC)1 variant paradoxically overwhelms the conventional PRC-mediated gene silencing in activated endothelial cells.

8 Feb 2022

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

A team of scientists led by Cold Spring Harbor Laboratory (CSHL) have discovered that disulfiram, an FDA-approved drug, prevents the immune system from producing toxic webs known as neutrophil extracellular traps (NETs).

8 Feb 2022

People with spinal cord injuries most likely to develop psychological conditions, study shows

Adults living with spinal cord injuries have a near-80% increased risk of developing psychological conditions, such as depression and anxiety, compared to people without the traumatic injury, a new study shows. But chronic pain may have an equally large, negative effect on mental health.

8 Feb 2022

Defective mitochondrial DNA could be modified using gene-editing techniques

Defective mitochondria – the 'batteries' that power the cells of our bodies – could in future be repaired using gene-editing techniques.

8 Feb 2022

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Mycology and immunology researchers from The University of Texas at San Antonio have been selected to receive a five-year, $6.8 million grant from the National Institutes of Health to establish a San Antonio-based Coccidioidomycosis Collaborative Research Center (SA-CCRC) focused on developing therapeutics and vaccines against coccidioidomycosis.

8 Feb 2022

Research News and Research

Researchers discover a molecular indicator and regulator of social isolation in female mice

Surveillance for potentially zoonotic viruses in rodent and bat populations in an agricultural settlement in Ghana

Polio, chickenpox, measles, now covid. It’s time to consult history on school vaccine mandates

Study finds 50% increase in hospitalizations for alcoholic hepatitis in early months of the pandemic

30-year-old cancer drug could get another shot, study says

Reducing mucin secretion provides a way to control chemoresistance of colorectal cancers

Research provides insights into the effects of Covid-19 lockdown on early development

Antarctic soil sample from 2018 adds to the enigma of the COVID-19 pandemic

Reviewing breath biomarkers for inflammatory respiratory diseases

Old FDA-approved drug may protect against lung injury and blood clots in severe COVID-19

Researchers identify a bivalent histone-mark switch essential for angiogenesis

FDA-approved drug prevents the immune system from producing neutrophil extracellular traps

People with spinal cord injuries most likely to develop psychological conditions, study shows

Defective mitochondrial DNA could be modified using gene-editing techniques

UTSA awarded $6.8 million grant to establish a Coccidioidomycosis Collaborative Research Center

Study shows how gut bacteria could undermine immunity in pancreatic cancer

Discovery may aid in the development of new treatments for osteoporosis

Gut microbiome modulation induces behavioral, cognitive changes in Alzheimer's disease model

Compounds used to fight fungal diseases in plants may be driving antimicrobial resistance

Swedish study shows fully vaccinated are protected against severe COVID-19

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence